Literature DB >> 9191473

Tumor progression and cellular differentiation of pulmonary adenocarcinomas in SV40 large T antigen transgenic mice.

K A Wikenheiser1, J A Whitsett.   

Abstract

Transgenic mice harboring the SV40 early region genes under transcriptional control of regulatory regions from the human surfactant protein C (SP-C) gene were used to study the progression of pulmonary adenocarcinomas in vivo. SP-C/SV40 early region gene (SP-C/TAg) transgenic mice consistently developed pulmonary adenocarcinomas. Distinct neoplasia was first detected at 4 wk of age and large tumor nodules were observed by 20-29 wk of age. SV40 large T mRNA was detected in distal bronchiolar and alveolar epithelial cells prior to tumor formation and in neoplastic cells at all stages of tumor development. SV40 large T mRNA correlated with cyclin-dependent kinase 1 (cdk1) mRNA expression, a marker of cellular proliferation. The nonciliated bronchiolar cell marker, CC10 mRNA, was detected in the majority of lung tumors at all ages, but was consistently decreased in the larger tumor nodules at later stages of tumor progression. CC10 mRNA was not detected in multiple murine lung epithelial (MLE) cell lines derived from the SP-C/TAg mice when cultured in vitro; but was induced in the MLE-15 clonal cell line when propagated in vivo in the flanks of nude mice. SP-C mRNA, an alveolar Type II cell marker, was also expressed in the MLE-15 cells when grown in nude mice. However, CC10 and SP-C mRNAs were expressed in distinct, nonoverlapping regions of the MLE-15 tumors. These studies support the concept that tumor progression is associated with changes in respiratory epithelial cell differentiation, and that the expression of bronchiolar and alveolar cell specific markers can be induced in a clonal cell line with changes in cellular environment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191473     DOI: 10.1165/ajrcmb.16.6.9191473

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  7 in total

1.  p63 is the molecular switch for initiation of an epithelial stratification program.

Authors:  Maranke I Koster; Soeun Kim; Alea A Mills; Francesco J DeMayo; Dennis R Roop
Journal:  Genes Dev       Date:  2004-01-16       Impact factor: 11.361

2.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Surfactant protein C expression in urethane-induced murine pulmonary tumors.

Authors:  R J Mason; M Kalina; L D Nielsen; A M Malkinson; J M Shannon
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

4.  Tumors in mice transgenic for the envelope protein of Jaagsiekte sheep retrovirus.

Authors:  Raffy M Dakessian; Yasuo Inoshima; Hung Fan
Journal:  Virus Genes       Date:  2006-10-17       Impact factor: 2.332

5.  A dominant negative variant of RAB5B disrupts maturation of surfactant protein B and surfactant protein C.

Authors:  Huiyan Huang; Jiehong Pan; David R Spielberg; Neil A Hanchard; Daryl A Scott; Lindsay C Burrage; Hongzheng Dai; David Murdock; Jill A Rosenfeld; Ariz Mohammad; Tao Huang; Anika G Lindsey; Hyori Kim; Jian Chen; Avinash Ramu; Stephanie A Morrison; Zachary D Dawson; Alex Z Hu; Eric Tycksen; Gary A Silverman; Dustin Baldridge; Jennifer A Wambach; Stephen C Pak; Steven L Brody; Tim Schedl
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-08       Impact factor: 12.779

6.  Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats.

Authors:  Sarah J Bolton; Kate Pinnion; Victor Oreffo; Martyn Foster; Kent E Pinkerton
Journal:  Respir Res       Date:  2009-11-24

Review 7.  Single and Multiple Gene Manipulations in Mouse Models of Human Cancer.

Authors:  Heather L Lehman; Douglas B Stairs
Journal:  Cancer Growth Metastasis       Date:  2015-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.